본문 바로가기

Limited prognostic value of dual time point F-18 FDG PET/CT in patients with early stage (stage I & II) non-small cell lung cancer (NSCLC)

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1
저널
RADIOTHERAPY AND ONCOLOGY98(1) · pp.105 · 2011
피인용
Web of Science 26
JCR IF
JCR 2010 4.337
ISSN
0167-8140

저자

  1. 김성장제1저자교신저자Medical Research Institute, School of Medicine, Pusan National University, South Korea
  2. Kim, Yong-KiPrivate Clinic of Endocrinology and Metabolism and Nuclear Medicine, South Korea
  3. 김인주Medical Research Institute, School of Medicine, Pusan National University, South Korea
  4. 김영대Department of Thoracic and Cardiovascular Surgery, Pusan National University, South Korea
  5. 이민기Department of Internal Medicine, Pusan National University, South Korea

초록

Objective: The aim of the current study was to investigate the prognostic value of dual time point F-18 FDG PET/CT in patients with early stage (stage I & II) NSCLC. Methods: A retrospective review identified 66 patients with surgically resected early (stage I & II) NSCLC who received dual time point F-18 FOG PET/CT at diagnosis of cancer. Survival analysis was conducted using Kaplan-Meier analysis, and survival curves stratified by age, sex, mediastinal lymph node involvement, TNM staging, SUVmaxE, SUVmaxD, and %Delta SUVmax were generated for estimation of overall survival and disease-free survival (DFS). Independent predictive factors for survival were determined using Cox proportional hazard model. Results: The overall survival and DFS were better in patients with tumor SUVmaxE <= 5.75 than the patients with tumor SUVmaxE >= 5.75. Seventeen patients (18.2%) with a tumor SUVmaxD >= 6.8 and 4 of 33 patients with tumor SUVmaxD <= 6.8 recurred during follow-up period. The median disease-free survival of the patients with tumor SUVmaxD >= 6.8 was 31.7 months and was significantly worse than the patients with tumor SUVmaxD <= 6.8 (Log rank test, X-2 = 10.45, p = 0.0012). The %Delta SUVmax did not have prognostic values for overall survival and disease-free survival. The SUVmaxE and SUVmaxD were the potent predictors for overall survival. Also, the potent predictor of DFS was the SUVmaxE. Conclusion: In conclusion, %Delta SUVmax measured by dual time point F-18 FDG PET/CT might not have a prognostic value for overall survival and DFS in surgically resected early stage (stage I & II) NSCLC. (C) 2010 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 98 (2011) 105-108

키워드

Dual time pointF-18 FDGNon-small cell lung cancerOverall survivalDisease-free survivalPOSITRON-EMISSION-TOMOGRAPHYPANCREATIC-CANCERNECK-CANCERRADIOTHERAPYRECURRENCESURVIVALHEADCT

식별자

WoS UID
000286994400018